Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis-Reference-Cited by-同舟云学术

Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis

Published:2015-06-29 Issue:5 Volume:42 Page:504-514
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Rutgeerts P.¹,Feagan B. G.²,Marano C. W.³,Padgett L.³,Strauss R.³,Johanns J.³,Adedokun O. J.³,Guzzo C.³,Zhang H.³,Colombel J.-F.⁴⁵,Reinisch W.⁶,Gibson P. R.⁷,Sandborn W. J.⁸,

Affiliation:

1. University Hospital; Gasthuisberg Leuven Belgium

2. Robarts Research Institute; University of Western Ontario; London ON Canada

3. Janssen Research & Development; LLC; Spring House PA USA

4. Hôpital Claude Huriez; Lille Cedex France

5. Icahn School of Medicine at Mount Sinai; New York NY USA

6. Universitätsklinik für Innere Medizin IV; Vienna Austria

7. Alfred Hospital; Melbourne VIC Australia

8. University of California San Diego; La Jolla CA USA

Funder

Janssen Research and Development

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13291/fullpdf

Reference20 articles.

1. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis;Sandborn;Gastroenterology,2012

2. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

3. Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study;Kay;Arthritis Rheum,2008

4. Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study;Keystone;Ann Rheum Dis,2010

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Efficacy of Vedolizumab, Ustekinumab, and Golimumab in the Management of Inflammatory Bowel Disease and the Combined Role of Nutritional Therapy with Biologics: A Review;Biologics;2024-08-30

2. The Future of Clinical Trials in Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2024-07

3. Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials;eClinicalMedicine;2024-06

4. Biologics in Focus: A Comprehensive Review of the Current Biological Therapies for Ulcerative Colitis in the United Arab Emirates (UAE);Gastrointestinal Disorders;2024-03-01

5. Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins;Clinical Pharmacology & Therapeutics;2024-01-18